Unicancer
Sidick DAOUDA is an experienced IT and Business Intelligence professional currently serving as Chef de Projet IT/BI at Unicancer since November 2020. Previously, Sidick worked as an Analyste Business Intelligence at Boccard from October 2019 to November 2020. Additional experience includes project management roles at Université Toulouse 1 Capitole, where Sidick contributed to website design, database projects using Oracle, and research on artificial intelligence in autonomous vehicles. Earlier roles involved accounting assistance at SOCIETE MULTINATIONALE COBEXIM SARL and an internship at the Ministry of Economy and Finance. Sidick holds a Master 2 in Information Systems Engineering from Université Toulouse 1 Capitole, as well as previous degrees in various fields of study from the same institution and Ecole d'administration.
This person is not in any teams
Unicancer
UNICANCER groups together the 20 French Comprehensive Cancer Centres (FCCCs) which are private, not-for-profit hospitals located across the French territory. FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education. They contribute to the public hospital service in accordance with statutory fees, with no additional charge. UNICANCER is one of the largest cancer care and research organisations in Europe. Via its R&D department, it sponsors clinical trials to improve cancer patients’ care and access to innovation, particularly in areas neglected by the pharmaceutical industry. UNICANCER is accredited by the French Ministry of Health and is eligible for public grants. The French Comprehensive Cancer Centres in numbers: • 20 sites located throughout the French territory • 19,000 employees • >135,000 patients hospitalised each year • Approximately 500 active clinical trials • 17% of the patients treated are included in a clinical trial (vs an average of 8.5% of cancer patients in France) • 19 molecular biology platforms certified by the French National Cancer Institute • 7 integrated cancerology research sites (SIRIC) certified by the French NCI (out of 8) • 12 early-phase clinical trial Centres (CLIP²) certified by the French NCI (out of 16) • 5th for global publications in oncology • 32% of French publications in oncology (articles in which FCCCs have participated) UNICANCER sponsors • 76 ongoing clinical trials (2016) • Including 5400 patients (2016) • From 270 investigator sites (2015), • With 20% located in other European countries